iCAD to Present Corporate Overview at the 31st Annual ROTH Conference
NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer, will be meeting with investors in a one-on-one format at the 31st Annual ROTH Conference, being held March 17-19 in Laguna Niguel, California. A pre-recorded webcast of the corporate overview will be available at http://wsw.com/webcast/roth33/icad/.
About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Investor Relations:LifeSci AdvisorsJeremy Feffer(212) 915-2568 firstname.lastname@example.org
Media Inquiries:ARPR, on behalf of iCAD, Inc.Paul Barren(855) 300-8209 email@example.com